| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |